NCLT: Suspended Directors Who are Prospective Resolution Applicants Cann’t Access Valuation Reports  ||  Supreme Court Clarifies Test For Granting Bail to Accused Added at Trial under Section 319 CrPC  ||  SC: Fresh Notification For Vijayawada ACB Police Station not Required After AP Bifurcation  ||  SC: Studying in a Government Institute Does Not Create an Automatic Right to a Government Job  ||  NCLT Mumbai: CIRP Claims Cannot Invoke the 12-Year Limitation Period For Enforcing Mortgage Rights  ||  NCLAT: Misnaming Guarantor as 'Director' in SARFAESI Notice Doesn't Void Guarantee Invocation  ||  Jharkhand HC: Mere Breach of Compromise Terms by an Accused Does Not Justify Bail Cancellation  ||  Cal HC: Banks Cannot Freeze a Company's Accounts Solely Due To ROC Labeling a 'Management Dispute'  ||  Rajasthan HC: Father’s Rape of His Daughter Transcends Ordinary Crime; Victim’s Testimony Suffices  ||  Delhi HC: Judge Who Reserved Judgment Must Deliver Verdict Despite Transfer; Successor Can't Rehear    

Delhi HC Seeks Centre's Response on How It Intends to Obtain Supply of Tocilizumab Drug - (17 May 2021)

CIVIL

Delhi High Court has sought Centre's response on the demand of Tocilizumab drug and how does the Centre intend to obtain the supplies of the said drug through Roche India and other global manufacturers, observing that no assurance was given by Roche India, which enjoys the license of manufacturing Tocilizumab 400 mg, if any further stock can be supplied to India.

Tags : DELHI HIGH COURT   SUPPLY OF TOCILIZUMAB DRUG  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved